Considering the tumor suppressing function of FOXO3, rs17069665 and rs4946936 might influence RMS risk and prognosis via regulating the expression of FOXO3 by altering the bindings to MYC, CTCF and/or RELA. Here, CTCF is linked to neoplasm.